Leiomyosarcoma of the scalp and lower leg skin. Clinical cases and literature review

Malignant soft tissue tumors localized in the skin, particularly leiomyosarcoma, are rare. Cutaneous leiomyosarcomas could have superficial and deep forms, while subcutaneous leiomyosarcomas are usually nodular. The tumor can spread to the underlying muscle fascia. The immunophenotype of leiomyosarcoma is determined by the following antibodies: ASMA, desmin, and N-caldeston; expression of PanCK is also possible. Researchers do not have any common opinion on the clinical course and biological behavior of cutaneous leiomyosarcomas. This is probably due to the tumor heterogeneity and the carcinogenesis specificity associated with molecular genetic changes. We detected these tumors at the histological examination which resulted in an analysis of the literature and our own material. We analyzed cutaneous tumors diagnosed in 2522 patients during 5 years (2016–2020). Squamous cell and basal cell histotypes were the most common ones. We did not diagnosed cutaneous leiomyosarcoma in our material during this period. This article presents two cases of cutaneous leiomyosarcoma localized in the scalp and calf skin. Morphological and immunohistochemical profiles of the tumors are described. The immunohistochemical analysis confirmed the morphological diagnosis and established the tumor immunophenotypes. The morphological diagnosis in one case was complicated due to the rarity of this pathology and the ambiguity of the interpretation of histological changes. Analysis of histological preparations and immunohistochemical study allowed verification of the tumor as leiomyosarcoma with its characteristic immunophenotype. All of the above demonstrate the need to perform morphological and immunohistochemical tests in specialized research cancer centers.

1. NCCN Guidelines for Patients: Soft Tissue Sarcoma, 2020. Available at: https://www.nccn.org/patients/guidelines/content/PDF/sarcoma-patient.pdf. Accessed: 03.06.2020.

2. Shah J, Patel S, Singh B, Wong R. Head and Neck Surgery and Oncology. 5th ed. New York: Elsevier, 2020, 896 p.

3. Soft tissue sarcomas: a guide for patients. Information based on ESMO Clinical Practice Guidelines, 2016. Available at: https://www.esmo.org/content/download/75509/1380040/file/esmo-acf-soft-tissue-sarcomas-guide-for-patients.pdf. Accessed: 03.06.2020.

4. Crowson AN, Margot S, Mim MS. Interpretation of skin biopsies. Primary lymphoid tumors of the skin. Trans. from English. edited by O.R. Katunin. Moscow: Practical Medicine, 2019, 520 p. (In Russ.).

5. Cutaneous leiomyosarcoma (atypical smooth muscle tumors). In: Elder DE, Massi D, Scolyer RA, Willemze R, eds. WHO Classification of Skin Tumours. 4th ed. Lyon, France: IARC; 2018;11:330–331.

6. Satbaeva EB, Mukhametgaliev NA, Iskakova EE. Cutaneous leiomyosarcoma / atypical smooth muscle sarcoma. Oncology and Radiology of Kazakhstan. 2020;(2(56)):22–25. (In Russ.).

7. Leiomyosarcoma. The WHO classification of Tumors. Soft Tissue and Bone Tumors. 5th Edition. 2020;3:195–197.

8. Wang W-L, Bones-Valentin RA, Prieto VG, Pollock RE, Lev DC, Lazar AJ. Sarcoma metastases to the skin: a clinicopathologic study of 65 patients. Cancer. 2012 Jun 1;118(11):2900–2904. https://doi.org/10.1002/cncr.26590

9. Kraft S, Fletcher CDM. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous “leiomyosarcoma”. Am J Surg Pathol. 2011 Apr;35(4):599–607. https://doi.org/10.1097/PAS.0b013e31820e6093

10. Kit OI, Shaposhnikov AV. General carcinogenesis of theory-model (manual for doctors) monograph. Rostov-on-Don: LLC "ID Mercury", 2021, 128 p. (In Russ.).

11. Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon MEH, van Spaendonck KY, et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011 Jan;79(1):49–59. https://doi.org/10.1111/j.1399-0004.2010.01486.x

12. Massi D, Franchi A, Alos L, Cook M, Di Palma S, Enguita AB, et al. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases. Histopathology. 2010 Jan;56(2):251–262. https://doi.org/10.1111/j.1365-2559.2009.03471.x